Continued antidepressant treatment and suicide in patients with depressive disorder

Archives of Suicide Research

Volumn 11, Issue 2, 2007, Pages 163-175

  SØndergØrd, Lars ^a   Lopez, Ana Garcia ^b   Andersen, Per Kragh ^b   Kessing, Lars Vedel ^a  

^a Rigshospitalet   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Antidepressive agents; Pharmacoepidemiology; Suicide

Indexed keywords

ANTIDEPRESSANT AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; DENMARK; DEPRESSION; FEMALE; HOSPITAL DISCHARGE; HUMAN; MALE; MENTAL HOSPITAL; MIDDLE AGED; PSYCHOLOGICAL ASPECT; REGRESSION ANALYSIS; SEX RATIO; STATISTICS; SUICIDE; TIME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIDEPRESSIVE AGENTS; DENMARK; DEPRESSIVE DISORDER; FEMALE; HOSPITALS, PSYCHIATRIC; HUMANS; MALE; MIDDLE AGED; PATIENT DISCHARGE; REGRESSION ANALYSIS; SEX DISTRIBUTION; SUICIDE; TIME FACTORS;

EID: 33947704075     PISSN: 13811118     EISSN: 15436136     Source Type: Journal    
DOI: 10.1080/13811110701249889     Document Type: Article

References (52)

1. American Psychiatric Association. (2003). Practice guideline for the assessment and treatment of patients with suicidal behaviors. American Psychiatric Association.
2. Andersen, U. A., Andersen, M., Rosholm, J. U. et al. (2000). Contacts to the health care system prior to suicide: A comprehensive analysis using registers for general and psychiatric hospital admissions, contacts to general practitioners and practising specialists and drug prescriptions. Acta Psychiatrics Scandinavica, 102, 126-134.
3. Andersen, U. A., Andersen, M., Rosholm, J. U. et al. (2001). Psychopharmacological treatment and psychiatric morbidity in 390 cases of suicide with special focus on affective disorders. Acta Psychiatrica Scandinavica, 104, 458-465.
4. Angst, F., Stassen, H. H., Clayton, P. J. et al. (2002). Mortality of patients with mood disorders: Follow-up over 34-38 years. Journal of Affictive Disorders, 68, 2-3.
5. Appleby, L., Dennehy, J. A., Thomas, C. S. et al. (1999a). Aftercare and clinical characteristics of people with mental illness who commit suicide: A case-control study. The Lancet, 353, 1397-1400.
6. Appleby, L., Shaw, J., Amos, T. et al. (1999b). Suicide within 12 months of contact with mental health services: National clinical survey. The British Medical Journal, 318, 1235-1239.
7. Bauer, M., Whybrow, P. C., Angst, J. et al. (2002a). World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for biological treatment of unipolar depressive disorders, Part 2: Maintenance treatment of major depressive disorder and treatment of chronic depressive disorders and subtreshold depressions. The World Journal of Biological Psychiatry, 3, 69-86.
8. Bauer, M., Whybrow, P. C., Angst, J. et al. (2002b). World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Acute and continuation treatment of major depressive disorder. The World Journal of Biological Psychiatry, 3, 5-43.
9. Cantor, C. (2000). Suicide in the western world. In K. Hawton & K. V. Heeringen (Eds.), The international handbook of suicide and attempted suicide (pp. 9-28). Chichester: John Wiley & Sons, Ltd.
10. Clayton, D. & Hills, M. (1993). Statistical models in epidemiology. Oxford: Oxford University Press.
11. Frank, E., Kupfer, D. J., Perel, J. M. et al. (1990). Three-year outcomes for maintenance therapies in recurrent depression. Archives of General Psychiatry, 47, 1093-1099.
12. Gibbons, R. D., Hur, K., Bhaumik, D. K. et al. (2005). The relationship between antidepressant medication use and rate of suicide. Archives of General Psychiatry, 62, 165-172.
13. Goldacre, M., Seagroatt, V., & Hawton, K. (1993). Suicide after discharge from psychiatric inpatient care. The Lancet, 342, 283-286.
14. Goldney, R. D. (2006). Suicide and antidepressants: What is the evidence? Australian and New Zealand Journal of Psychiatry, 40, 381-385.
15. Gunnell, D., Saperia, J., & Ashby, D. (2005). Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: Meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review. The British Medical Journal, 330, 385.
16. Harris, E. C. & Barradough, B. (1997). Suicide as an outcome for mental disorders. A meta-analysis. The British Journal of Psychiatry, 170, 205-228.
17. Healy, D. (2003). Lines of evidence on the risks of suicide with selective serotonin reuptake inhibitors. Psychotherapy and Psychosomatics, 72, 71-79.
18. Helgason, T., Tomasson, H., & Xoega, T. (2004). Antidepressants and public health in Iceland: Time series analysis of national data. The British Journal of Psychiatry, 184, 157-162.
19. Hiroeh, U., Appleby, L., Mortensen, P. B. et al. (2001). Death by homicide, suicide, and other unnatural causes in people with mental illness: A population-based study. The Lancet, 358, 2110-2112.
20. Hirschfeld, R. M. A. (2000). Suicide and antidepressant treatment. Archives of General Psychiatry, 57, 325-326.
21. Hoyer, E. H. (2002). Causes of death and risk factors for suicide in patients hospitalised during the period 1973-1995 with an affective disorder. Faculty of Health Sciences, University of Aarhus, Aarhus.
22. Hoyer, E. H., Mortensen, P. B., & Olesen, A. V. (2000). Mortality and causes of death in a total national sample of patients with affective disorders admitted for the first time between 1973 and 1993. The British Journal of Psychiatry, 176, 76-82.
23. Hoyer, E. H., Olesen, A. V., & Mortensen, P. B. (2004). Suicide risk in patients hospitalised because of an affective disorder: A follow-up study, 1973-1993. Journal of Affective Disorders, 78, 209-217.
24. Isacsson, G. (2000). Suicide prevention - a medical breakthrough? Acta Psychiatrics Scandinavica, 102, 113-117.
25. Isacsson, G., Holmgren, P., Druid, H. et al. (1997). The utilization of antidepressants - a key issue in the prevention of suicide: An analysis of 5281 suicides in Sweden during the period 1992-1994. Acta Psychiatrica Scandinavica, 96, 94-100.
26. Juel, K. & Helweg-Larsen, K. (1999). The Danish registers of causes of death. The Danish Medical Bulletin, 46, 354-357.
27. Kessing, L. V., Hansen, H. V., Demyttenaere, K. et al. (2005a). Depressive and bipolar disorders: Patients' attitudes and beliefs towards depression and antidepressants. Psychological Medicine, 35, 1205-1213.
28. Kessing, L. V., Hansen, M. G., & Andersen, P. K. (2004). Course of illness in depressive and bipolar disorders. Naturalistic study, 1994-1999. The British Journal of Psychiatry, 185, 372-377.
29. Kessing, L. V. & Munk-Jorgensen, P. (2004). Does type of first contact in depressive and bipolar disorders predict subsequent hospitalisation and risk of suicide? Journal of Affective Disorders, 83, 65-71.
30. Kessing, L. V., Olsen, R. W., & Andersen, P. K. (1999). Recurrence in affective disorder: Analyses with frailty models. American Journal of Epidemiology, 149, 404-411.
31. Kessing, L. V., Sondergard, L., Kvist, K. et al. (2005b). Suicide risk in patients treated with lithium. Archives of General Psychiatry, 62, 860-866.
32. Kupfer, D. J., Frank, R., Perel, J. M. et al. (1992). Five-year outcome for maintenance therapies in recurrent depression. Archives of General Psychiatry, 49, 769-773.
33. Lewis, E., Marcus, S. C., Olfson, M. et al. (2004). Patients' early discontinuation of antidepressant prescriptions. Psychiatric Services, 55, 494.
34. Malig, C. (1996) The civil registration system in Denmark II. VRS technical paper, no 66. International Institute for Vital Registration and Statistics.
35. Maris, R. W. (2002). Suicide. The Lancet, 360, 319-326.
36. McClure, G. M. (2000). Changes in suicide in England and Wales, 1960-1997. The British Journal of Psychiatry, 176, 64-67.
37. Mortensen, P. B., Agerbo, E., Erikson, T. et al. (2000). Psychiatric illness and risk factors for suicide in Denmark. The Lancet, 355, 9-12.
38. Munk-Jorgensen, P. & Mortensen, P. B. (1997). The Danish psychiatric central register. The Danish Medical Bulletin, 44, 82-84.
39. Neutel, C. I. & Patten, S. B. (1997). Risk of suicide attempts after benzodiazepine and/or antidepressant use. Annals of Epidemiology, 7, 568-574.
40. Office for Official Publications of the European Communities. (1995). Statistics on Persons in Denmark. A register-based statistical system. Office for Official Publications of the European Communities, Eurostat, Luxemburg.
41. Oquendo, M. A., Malone, K. M., Ellis, S. P. et al. (1999). Inadequacy of antidepressant treatment for patients with major depression who are at risk for suicidal behavior. The American Journal of Psychiatry, 156, 190-194.
42. Qin, P., Agerbo, E., Westergard-Nielsen, N. et al. (2000). Gender differences in risk factors for suicide in Denmark. The British Journal of Psychiatry, 177, 546-550.
43. Rihmer, Z. (2004). Decreasing national suicide rates-fact or fiction? The World Journal of Biological Psychiatry, 5, 55-56.
44. Sorensen, H. T. & Larsen, B. O. (1994). A population-based Danish data resource with possible high validity in pharmacoepidemiological research. Journal of Medical Systems, 18, 33-38.
45. Statistics Canada, (2004). Suicides, and suicide rate, by sex and by age group. Available at: http://www.statcan.ca/english/Pgdb/health01.htm. Accessed on 28 August 200ch6.
46. Statistics Denmark. (1997). SOCIO Danmarks statistics socioekonomiske klassifikation. Copenhagen: Statistics Denmark.
47. Statistics Norway. (2004). Causes of death. Available at: http://www.ssb.no/english/subjects/03/01/10/dodsarsak_en/tab-2005-03-30-08-en. html. Accessed on 28 March 2006.
48. The Danish Medicines Agency. (2003). Medicinal product statistics 1998-2002 Denmark. Copenhagen: The Danish Medicines Agency.
49. The Danish Medicines Agency. (2004). Forbruget af antidepressiva i Danmark i den primscre sundhedssektor i perioden 1994-2003. Available at: http://www.laegemiddelstyrelsen.dk/publikationer/netpub/forbrugsanalyser/ antidepressiva/. Accessed on 28 August 2006.
50. The Medicines and Health Regulatory (2003). Interim report of the Committee on Safety of Medicines' Expert Working Group on Selective Serotonin reuptake Inhibitors, September 2003. Available at: http://www.mca.gov.uk/ ourwork/monitorsafequalmed/safetymessages/ssriewgintermreportfinal.pdf. Accessed on 16 November 2003.
51. Van Praag, H. M. (2005). The resistance of suicide: Why havent antidepressants reduced suicide rates? In K. Hawton (Ed.), Prevention and treatment of suicidal behaviour, (pp. 239-260). Oxford: Oxford University Press.
52. Wessely, S. & Kerwin, R. (2004). Suicide risk and the SSRIs. The Journal of the American Medical Association, 292, 379-381.